Stemtech Corp. Forms Joint Venture With Lightway Ventures to Enter China Market
I'm PortAI, I can summarize articles.
Stemtech Corp. has formed a joint venture with Lightway Ventures to enter the China market, establishing Stemtech Asia (Hong Kong) for distributing stem cell nutrition products. Stemtech holds a 51% stake, Lightway Ventures 49%, with profits split equally. The venture targets major e-commerce and pharmacy channels, planning local manufacturing and initial rollout in Shanghai and Beijing, pending funding and regulatory approvals.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments